Loading
No insider purchase over the last 90 days. The latest, by MARSHALL ALLAN, was filed 23 Dec 2025.
Upexi, Inc.: what insiders have been doing
Upexi, Inc., classified in the Media sector, is a listed company. Its insiders report their share dealings to SEC (Form 4). Over the twelve months to 22 October 2026, 8 filings were filed, from 3 insiders.
No insider sold shares on the market over the period. Instead, the filings list 6 purchases totalling €921k, made by 2 insiders. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The buyers include 1 senior executive and 1 chief executive. Salkind Gene filed the largest purchase, €242k, on 18 November 2025.
The latest purchase dates back some time: it was published 304 days ago, on 23 December 2025. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4.
For context, the typical company on the same exchange (median of 5,462 companies) published 28 filings over the same period, against 8 filings here. Our records for Upexi, Inc. go back to 2022, with 38 purchases and no sales on the open market in total. For the fiscal year to 30 June 2026, the annual 10-K puts revenue at 25.0 m USD and net income at -246.1 m USD.
In the same sector, recent insider purchases at Liberty Latin America Ltd. and PodcastOne, Inc. also feature in our signals. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
51
Thresholds
n/a
Buy Volume
€5M
38 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleAllan Marshall5 buys
Gene Salkind5 buys
Lawrence Dugan4 buys
Andrew James Norstrud1 buy
Since the insiders bought
- -78.0%Entry US$11.20 · Close at T+365 US$2.46
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Financial data
as of FY 2026FY ended June 2026 · cache
US$0.91
Analyst consensus
1 analysts1.00/5
US$2.00Target US$2.00(+120%)US$2.00
Income statement
RevenueUS$25M
Gross profitUS$22.4M89% margin
EBITDA-US$31.5M-126% margin
Net income-US$246.1M-984.3% margin
Valuation
PER (trailing)1.4x
PER (forward)-7.0x
P/Book1.3x
Beta-0.23
Balance sheet & cash
Market capUS$74.7M
Total debtUS$224.1M
Free Cash Flow-US$21M
Profitability & ownership
ROE-1356.3%
ROA-98.2%
% insiders11.5%
% institutions25.9%
Last declaration on 23 December 2025
Declarations51 total
50,000 shares@ US$1.80Common StockSEC:0001477932-25-009188:0
Canonical exit: 23 Mar 2026 (T+90)
1,600,000 shares0Common StockSEC:0001477932-25-009027:0
100,000 shares@ US$2.07Common StockSEC:0001477932-25-009027:1
Canonical exit: 15 Mar 2026 (T+90)
50,000 shares@ US$2.07Common StockSEC:0001477932-25-009027:2
Canonical exit: 16 Mar 2026 (T+90)
50,000 shares@ US$2.55Common StockSEC:0001477932-25-008535:0
Canonical exit: 18 Feb 2026 (T+90)
240,000 shares0Common StockSEC:0001477932-25-008534:0
100,000 shares@ US$2.65Common StockSEC:0001477932-25-008466:0
Canonical exit: 15 Feb 2026 (T+90)
100,000 shares@ US$2.81Common StockSEC:0001477932-25-008466:1
Canonical exit: 15 Feb 2026 (T+90)
20,243 shares@ US$4.94Common StockSEC:0001477932-25-005338:0
Canonical exit: 9 Oct 2025 (T+90)
50,000 shares0Common StockSEC:0001477932-25-005338:1
150,000 shares0Common StockSEC:0001477932-25-005338:2
1,000 shares@ US$5.17Common StockSEC:0001477932-25-005238:0
Canonical exit: 13 Oct 2025 (T+90)
50,000 shares0Common StockSEC:0001477932-25-005238:1
50,000 shares0Common StockSEC:0001477932-25-005238:2
10,000 shares@ US$5.70Common StockSEC:0001477932-25-005238:3
Canonical exit: 14 Oct 2025 (T+90)
1,000 shares@ US$5.60Common StockSEC:0001477932-25-005238:4
Canonical exit: 14 Oct 2025 (T+90)
4,000 shares@ US$7.50Common StockSEC:0001477932-25-005238:5
Canonical exit: 20 Oct 2025 (T+90)
161,943 shares@ US$4.94Common StockSEC:0001477932-25-005236:0
Canonical exit: 9 Oct 2025 (T+90)
1,200,000 shares0Common StockSEC:0001477932-25-005236:1
250,000 shares0Common StockSEC:0001477932-25-005235:0
50,000 shares0Common StockSEC:0001477932-25-005237:0
50,000 shares0Common StockSEC:0001477932-25-005237:1
400,000 shares0Common StockSEC:0001477932-25-005239:0
241,229 shares@ US$2.28Common StockSEC:0001477932-25-002979:0
Canonical exit: 16 Jul 2025 (T+90)
657,895 shares@ US$2.28Common StockSEC:0001477932-25-002981:0
Canonical exit: 16 Jul 2025 (T+90)
25 of 51 declarations
About Upexi, Inc.
Upexi, Inc. is a company listed on the XNAS market. It specializes in the development and marketing of innovative products across various sectors.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
